Grants and Contributions:
Title:
BPE Technology Development
Agreement Number:
999756
Agreement Value:
$298,514.00
Agreement Date:
Jan 2, 2023 - Feb 29, 2024
Description:
Pegasus Biotech is developing the process and analytical methods to commercialize the BPE plasmid technology as a DNA plasmid production platform.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Charlottetown, Prince Edward Island, CA C1A 4P3
Reference Number:
172-2022-2023-Q4-999756
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
760829879
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 29 days.
Amendment Date
Dec 14, 2023
Recipient's Legal Name:
Pegasus Biotech Incorporated
Federal Riding Name:
Charlottetown
Federal Riding Number:
11002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: